| | | | | | | |
 | JOHNSON & JOHNSON | 1.13% | -1.20% | 4.94% | 6.24% | 26.30% | 472 389 |
| PFIZER, INC. | -0.23% | 4.67% | -11.41% | 31.66% | 17.82% | 293 506 |
| ELI LILLY AND COMPANY | 0.15% | 3.68% | 17.55% | 38.79% | 183.79% | 292 291 |
 | ROCHE HOLDING AG | 0.58% | 0.50% | -15.48% | -8.34% | 13.84% | 272 104 |
| ABBVIE INC. | 0.42% | 0.96% | 13.59% | 33.54% | 105.18% | 271 782 |
 | NOVO NORDISK A/S | -0.33% | -0.22% | 6.75% | 47.93% | 127.42% | 248 942 |
| MERCK & CO., INC. | 1.37% | -0.76% | 20.59% | 17.58% | 6.35% | 233 712 |
 | ASTRAZENECA PLC | -0.72% | -0.61% | 23.55% | 22.13% | 62.41% | 200 459 |
| NOVARTIS AG | -0.64% | -0.33% | 0.06% | -4.96% | -11.75% | 181 232 |
| BRISTOL-MYERS SQUIBB COMPANY | -0.21% | -2.68% | 23.24% | 14.77% | 65.03% | 163 597 |
| AMGEN INC. | 0.92% | 0.07% | 9.15% | -1.27% | 30.21% | 131 173 |
 | SANOFI | 1.22% | -3.02% | 10.09% | 10.94% | 24.64% | 126 838 |
| GSK PLC | 1.13% | 1.80% | 11.14% | 24.19% | 8.80% | 108 701 |
 | BAYER AG | 1.11% | -0.76% | 22.02% | 11.42% | -6.00% | 58 604 |
 | DAIICHI SANKYO CO., LTD. | 0.00% | 1.93% | 15.42% | 41.73% | 69.39% | 47 859 |
| | | | | | | |
| | Durchschnitt | 0.39% | 0.27% | 10.08% | 19.09% | 48.23% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 0.38% | 0.42% | 7.84% | 18.99% | 54.45% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
